Ultimately, the goal of a cancer vaccine is to aggressively activate the CD8+ T cell pathway, which is mediated by CD4+ T cells, overcoming self-tolerance and immune suppression and resulting in cancer cell eradication. This evidence concerns the gene CD4 and cancer.